These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2862896)

  • 1. Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics.
    Kroboth PD; Smith RB; Silver MR; Rault R; Sorkin MI; Puschett JB; Juhl RP
    Br J Clin Pharmacol; 1985 Jun; 19(6):839-42. PubMed ID: 2862896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of end-stage renal disease and aluminum hydroxide on temazepam kinetics.
    Kroboth PD; Smith RB; Rault R; Silver MR; Sorkin MI; Puschett JB; Juhl RP
    Clin Pharmacol Ther; 1985 Apr; 37(4):453-9. PubMed ID: 2858279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentration.
    Kroboth PD; Smith RB; Sorkin MI; Silver MR; Rault R; Garry M; Juhl RP
    Clin Pharmacol Ther; 1984 Sep; 36(3):379-83. PubMed ID: 6147221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
    Jochemsen R; Wesselman JG; van Boxtel CJ; Hermans J; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):291S-297S. PubMed ID: 6140948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
    Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam.
    Smith RB; Divoll M; Gillespie WR; Greenblatt DJ
    J Clin Psychopharmacol; 1983 Jun; 3(3):172-6. PubMed ID: 6135721
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Smith RB; Shader RI
    Clin Pharmacokinet; 1984; 9(2):177-83. PubMed ID: 6143633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure.
    Clarkson EM; Luck VA; Hynson WV; Bailey RR; Eastwood JB; Woodhead JS; Clements VR; O'Riordan JL; De Wardener HE
    Clin Sci; 1972 Oct; 43(4):519-31. PubMed ID: 4653591
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of muzolimine after oral administration with and without aluminium hydroxide in healthy volunteers.
    Ritter W; Hanisch M; Lücker PW; Venitz F; Hey B; Baykal N
    Z Kardiol; 1985; 74 Suppl 2():149-51. PubMed ID: 4002791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazolam and ethanol interaction: kinetic and dynamic consequences.
    Dorian P; Sellers EM; Kaplan HL; Hamilton C; Greenblatt DJ; Abernethy D
    Clin Pharmacol Ther; 1985 May; 37(5):558-62. PubMed ID: 2859136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic drug interaction between erythromycin and triazolam.
    Phillips JP; Antal EJ; Smith RB
    J Clin Psychopharmacol; 1986 Oct; 6(5):297-9. PubMed ID: 3771812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of influence of cigarette smoking on triazolam pharmacokinetics.
    Ochs HR; Greenblatt DJ; Burstein ES
    Br J Clin Pharmacol; 1987 Jun; 23(6):759-63. PubMed ID: 3606935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazolam disposition.
    Eberts FS; Philopoulos Y; Reineke LM; Vliek RW
    Clin Pharmacol Ther; 1981 Jan; 29(1):81-93. PubMed ID: 6109586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide.
    Shader RI; Georgotas A; Greenblatt DJ; Harmatz JS; Allen MD
    Clin Pharmacol Ther; 1978 Sep; 24(3):308-15. PubMed ID: 28870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aluminium hydroxide orally on calcium, phosphorus and aluminium metabolism in normal subjects.
    Cam JM; Luck VA; Eastwood JB; de Wardener HE
    Clin Sci Mol Med; 1976 Oct; 51(4):407-14. PubMed ID: 971581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population study of triazolam pharmacokinetics.
    Friedman H; Greenblatt DJ; Burstein ES; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Dec; 22(6):639-42. PubMed ID: 3567010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium carbonate can enhance aluminium absorption from aluminium hydroxide in patients with impaired renal function.
    Lin JL; Leu ML
    Nephrol Dial Transplant; 1996 Sep; 11(9):1891-3. PubMed ID: 8918652
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
    Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
    Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.